Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: T’is the Season for hot returns, or a lump of coal?

Once the U.S. Thanksgiving is in the rear-view, the mood among North American markets dramatically shifts. Traders must now juggle holidays, gifts, and vacations on one hand, and the end of their...

Morning Market Outlook for Nov. 22, 2023

Stephen Whiteside of TheUpTrend.com takes a close look at ETFs and what to watch in the stock market before U.S. Thanksgiving in the Morning Market Outlook for Wednesday. Navigate the dynamic world of market moves effortlessly and stay ahead of the game with daily updat...

Morning Market Outlook for Nov. 23, 2023

U.S. Thanksgiving means a quieter day, so Stephen Whiteside of TheUpTrend.com focuses on Canada in the Morning Market Outlook for Thursday. Navigate the dynamic world of market moves effortlessly and stay ahead of the game with daily updates on TSX, S&P 500, NASDAQ, gol...

Biotech Identifies Antibody with 100% SARS-CoV-2 Inhibition

The goal of Sorrento Therapeutics to develop a Covid-19 antibody cocktail, including its progress, next steps and market opportunity, is reviewed in a Dawson James report. In a May 26 research note, Dawson James analyst Jason Kolbert reported that Sorrento Therape...

Regeneron Shares Rise 10% on Advances in its Novel COVID-19 Antibody Program

Shares of Regeneron Pharmaceuticals rose to a new 52-week high price after the company reported it has identified hundreds of virus-neutralizing antibodies and plans to initiate large-scale manufacturing by mid-April of a multi-antibody therapy to treat coronavirus. ...

Important Economic News Calendar: November 25 – November 29, 2019

The global financial markets barely moved last week as economic data releases didn’t bring any meaningful surprises. So will the Thanksgiving holiday week bring volatility to the financial markets? Actually, we may see some market movements in the first half of...

Need-to-Know Numbers You Might Have Missed Last Week

Another year, another Thanksgiving. I hope all of my American friends and readers had the chance to spend some quality time with family as we begin the busy holiday shopping season. The leading retail trade group expects sales in November and December to increase as muc...

Smart Money Is Piling Into Oil

Oil prices jumped to five-month highs this week, pushed higher by a bullish cocktail of supply outages, geopolitical unrest and a sputtering shale sector. The most recent factor is the sudden eruption of the long simmering feud in Libya between rival factions. The attack o...

Buzz on the Bullboards: Crisis Creates Opportunity

As November draws to a close, many investors may take time to consider what they are thankful for. Even if the American Thanksgiving isn’t something you celebrate, there are a lot of reasons to be thankful these days, from having our health, to major stock...

HAVN Life Sciences: Using psychedelics, specifically mushrooms, to improve mental health

Mental health, as we know, controls a large part of how we interact with the world around us. Our next guest knows this and is working to improve the mental health of those struggling by using psychedelics, specifically mushrooms. Psychedelics are not federally l...
1 2 3 4 5 6